- Home
- LYTS vs XNCR Comparison
LYTS vs XNCR Comparison
Compare LYTS & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYTS
- XNCR
- Stock Information
- Founded
- LYTS 1976
- XNCR 1997
- Country
- LYTS United States
- XNCR United States
- Employees
- LYTS N/A
- XNCR N/A
- Industry
- LYTS Building Products
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- LYTS Consumer Discretionary
- XNCR Health Care
- Exchange
- LYTS Nasdaq
- XNCR Nasdaq
- Market Cap
- LYTS 518.5M
- XNCR 579.3M
- IPO Year
- LYTS N/A
- XNCR 2013
- Fundamental
- Price
- LYTS $16.73
- XNCR $8.27
- Analyst Decision
- LYTS Strong Buy
- XNCR Buy
- Analyst Count
- LYTS 2
- XNCR 7
- Target Price
- LYTS $26.00
- XNCR $27.50
- AVG Volume (30 Days)
- LYTS 106.0K
- XNCR 827.1K
- Earning Date
- LYTS 08-14-2025
- XNCR 08-04-2025
- Dividend Yield
- LYTS 1.20%
- XNCR N/A
- EPS Growth
- LYTS N/A
- XNCR N/A
- EPS
- LYTS 0.72
- XNCR N/A
- Revenue
- LYTS $547,316,000.00
- XNCR $127,228,000.00
- Revenue This Year
- LYTS $21.02
- XNCR N/A
- Revenue Next Year
- LYTS $7.32
- XNCR $28.84
- P/E Ratio
- LYTS $23.10
- XNCR N/A
- Revenue Growth
- LYTS 17.89
- XNCR N/A
- 52 Week Low
- LYTS $13.63
- XNCR $7.16
- 52 Week High
- LYTS $25.50
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- LYTS 59.06
- XNCR 41.69
- Support Level
- LYTS $16.10
- XNCR $8.01
- Resistance Level
- LYTS $16.52
- XNCR $8.73
- Average True Range (ATR)
- LYTS 0.35
- XNCR 0.51
- MACD
- LYTS 0.03
- XNCR -0.05
- Stochastic Oscillator
- LYTS 84.88
- XNCR 11.87
About LYTS LSI Industries Inc.
LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.